Clinical Trial Update: Feasibility Study of the FARAPULSE™ Cardiac Ablation System Plus in the Treatment of Persistent Atrial Fibrillation(PersAFOne II) [NA]

View source ↗

Summary

Clinical feasibility study of the FARAPULSE cardiac ablation system for persistent atrial fibrillation has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Persistent Atrial Fibrillation

Drugs mentioned

• FARAPULSE

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Persistent Atrial Fibrillation | NA | Status: COMPLETED | Results posted: 2024-01-31